|Bid||51.53 x 2200|
|Ask||51.47 x 3100|
|Day's Range||50.61 - 51.71|
|52 Week Range||33.36 - 54.94|
|Beta (5Y Monthly)||0.67|
|PE Ratio (TTM)||26.04|
|Earnings Date||Jan 31, 2022 - Feb 04, 2022|
|Forward Dividend & Yield||1.56 (3.98%)|
|Ex-Dividend Date||Jul 29, 2021|
|1y Target Est||46.23|
Fears of the new Omicron Covid variant slammed the stock market Friday. Here's what investors should do now. Li Auto earnings are on tap.
Fears of the new Omicron Covid variant slammed the stock market Friday. Here's what investors should be doing now. Li Auto earnings are on tap.
Qiagen closed higher Friday after the diagnostics company reaffirmed the efficacy of its PCR tests against the new Covid variant which scrambled stock markets on Friday. Qiagen (ticker: QGEN) said it assessed its SARS-CoV-2 PCR tests against the new genetic mutations of the variant, known by its scientific name, B.1.1.529. “We are pleased to report that the emergence of this new variant of concerns, as has been the case with other variants, has had no impact on the effectiveness of our SARS-CoV-2 PCR tests,” said Davide Manissero, chief medical officer at Qiagen.